The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
Fidelity Series Global ex US Index FSGEX
- NAV / 1-Day Return 15.64 / −1.01 %
- Total Assets 50.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.010%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 2.55%
- Turnover 6%
USD | NAV as of Oct 03, 2024 | 1-Day Return as of Oct 03, 2024, 10:11 PM GMT+0
Morningstar’s Analysis FSGEX
Will FSGEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 13.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 2.60 | 1.3 Bil | Technology |
Fidelity Cash Central Fund | 2.37 | 1.2 Bil | Cash and Equivalents |
MSCI EAFE Index Future Sept 24 | 1.76 | 870.4 Mil | — |
Novo Nordisk AS Class B | 1.62 | 797.6 Mil | Healthcare |
ASML Holding NV | 1.28 | 634.2 Mil | Technology |
Tencent Holdings Ltd | 1.14 | 564.5 Mil | Communication Services |
Nestle SA | 1.02 | 503.8 Mil | Consumer Defensive |
AstraZeneca PLC | 0.97 | 478.0 Mil | Healthcare |
Samsung Electronics Co Ltd | 0.95 | 468.0 Mil | Technology |
Novartis AG Registered Shares | 0.85 | 418.9 Mil | Healthcare |